VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AAPG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AAPGAscentage Pharma Group International
$13.01$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAAPGInstitutional Holders

AAPG logoAscentage Pharma Group International (AAPG) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership decreased this quarter (-0.01 pp), while top 10 holders maintain a highly concentrated 100.0% of value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
0.0%$264K total value · ▼ 0.01 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
52 / 100
Neutral
Institutions & Flow8 holders+1 net flow (+3 / -2)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+1)
  • Point72 Asset Management, L.p. maintains a significant position
  • Top 10 holders control 100.0% of institutional value
  • No Insider Signal

Top Institutional Holders of AAPG

Ranked by reported Q2 2026 13F market value

Top 10 Holders
100.0%
Top 25 Holders
100.0%

Share of total reported institutional value in AAPG held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1Point72 Asset Management, L.P.14K$243K-13.8%0.015%0.00%
2MORGAN STANLEY919$16K+84.5%0.001%0.00%
3WELLS FARGO & COMPANY/MN200$4K—0.000%0.00%
4EverSource Wealth Advisors, LLC24$4210.0%0.000%0.00%
5UBS Group AG15$263-87.9%0.000%0.00%
6BlackRock, Inc.6$105—0.000%0.00%
7Caitong International Asset Management Co., Ltd1$18—0.000%0.00%
8ROYAL BANK OF CANADA6$00.0%0.000%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in AAPG — a direct measure of their conviction.

Quarterly Institutional Activity

Filings activity in AAPG during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers3Added To1Trimmed3Exited2

New Buyers

3

Institutions that opened a new AAPG position in Q2 2026

  • WELLS FARGO & COMPANY/MN$4K
  • BlackRock, Inc.$105
  • Caitong International Asset Management Co., Ltd$18

Exited Positions

2

Institutions that fully closed their AAPG position in Q2 2026

  • XY Capital Ltd$311K
  • Tower Research Capital LLC (TRC)$12K

AAPG Institutional Ownership by Quarter

6 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 20268+14%0.02%0.01 pp$0M63%
Q1 2026742%0.03%0.02 pp$1M42%
Q4 20251214%0.05%0.05 pp$1M66%
Q3 202514+7.7%0.10%+0.01 pp$4M+14%
Q2 202513+86%0.09%0.16 pp$3M38%
Q1 20257—0.25%—$5M—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

How AAPG Compares to Peers

Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
DMRADamora Therapeutics, Inc.$1.46B200.0%99+33
FTHFaeth Therapeutics, Inc.$568M54.5%45+16
LONALeonaBio, Inc.$17M184.4%45+4
KYNBKyntra Bio, Inc.$15M26.9%29-4
CNSYCerenome, Inc.$5M4.8%24-5

AAPG — Frequently Asked Questions

Quick answers to the most common questions about buying AAPG stock.

What percentage of AAPG is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Ascentage Pharma Group International stands at 0.0%, held across 8 reporting institutions.

Who is the largest institutional holder of AAPG?

Point72 Asset Management, L.P. is the largest reported institutional holder of AAPG, with approximately 13,841 shares worth $0.00B as of Q2 2026.

Is AAPG a hedge fund favorite?

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of AAPG, including Point72 Asset Management, L.P..

What is AAPG's Smart Money Score?

Our composite Smart Money Score for AAPG is 52 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought AAPG this quarter?

3 institutions opened new positions in AAPG during Q2 2026, while 2 fully exited. 1 added to existing positions and 3 trimmed.

How is institutional ownership of AAPG changing?

AAPG institutional ownership fell by 0.01 percentage points quarter-over-quarter, with a net change of +1 holders.

How concentrated is AAPG ownership among the top holders?

The top 10 institutions account for 100.0% of all reported 13F value in AAPG, and the top 25 account for 100.0%.

How does AAPG compare to Oncology Biotech on institutional ownership?

Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), KYNB (26.9%), CNSY (4.8%). See the peer comparison table on this page for net buyer activity by company.

Where does this AAPG institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.